Sales & Marketing News | pharmaphorum

News

Largest BMS shareholder opposes Celgene deal

Bristol-Myers Squibb’s (BMS) largest shareholder has come out against the company’s planned merger with Celgene, putting the future of the deal in doubt.

News

Mylan reports lower than expected earnings

Mylan has reported lower than expected full year earnings and 2019 forecasts, thanks partly to delays in its generic Advair approval and continuing problems at its US manufacturing plant.

News

Makara Health promotes Katie Bright to director

Katie Bright has joined the leadership team at Makara Health, following her promotion to director at the UK-based healthcare communications agency.

News

Lucid Group Lighthouse Medical Communications US Lisa Druce

Lisa Druce joins Lucid’s Lighthouse as managing partner

Lighthouse Medical Communications US has appointed Lisa Druce as its new managing partner.

News

Rap video is latest evidence in Insys trial

A rap video used to motivate Insys Therapeutics’ salesforce into promoting higher doses of its opioid drug Subsys is the latest piece of evidence in the increasingly-bizarre trial of chairman Jo

News

Sanofi expects growth as rare disease drugs boost earnings

Sanofi’s strategy of betting on new drugs and biotech acquisitions seems to be paying off, as the company has forecast growth for 2019 thanks to higher than expected quarterly earnings and

Largest BMS shareholder opposes Celgene deal

Mylan reports lower than expected earnings

Makara Health promotes Katie Bright to director

Lisa Druce joins Lucid’s Lighthouse as managing partner

Rap video is latest evidence in Insys trial

Sanofi expects growth as rare disease drugs boost earnings

CEPI steps in to fund Moderna's pandemic flu jab

How to meet your physicians where they are online

News

Editor's Picks